Clinical Trials & Results

Search or filter the listing below to find a trial or results of a completed trial.

View Actively Recruiting Clinical Trials

Click here to see trials currently recruiting participants

Filter

Health Condition

Toggle

Study Status

Toggle

Age group

Toggle

Gender

Toggle

Phase

Toggle

Study Types

Toggle

Showing 20 of 247 Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma (CONNECT1)

respiratory-icon.png
Condition(s):
Asthma
Status:
Completed
Requirements:
13 Years and older
Interventions:
Drug: Albuterol eMDPI DS | Drug: albuterol

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma (CONNECT2)

respiratory-icon.png
Condition(s):
Asthma
Status:
Completed
Requirements:
13 Years and older
Interventions:
Drug: Fluticasone propionate/salmeterol (FS) | Drug: Albuterol | Drug: Standard of Care Asthma Medication | Drug: Standard of Care Rescue Medication

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine

headache-icon.png
Condition(s):
Migraine Headache
Status:
Completed
Requirements:
18 Years to 70 Years
Interventions:
Drug: Fremanezumab | Drug: Placebo

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia (SOLARIS)

disease-icon.png
Condition(s):
Schizophrenia
Status:
Completed
Requirements:
18 Years to 64 Years
Interventions:
Drug: TV-44749 | Drug: Placebo

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/​Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

respiratory-icon.png
Condition(s):
Asthma
Status:
Completed
Requirements:
12 Years and older
Interventions:
Drug: Fp/ABS, FP, ABS, Placebo

A Study to Assess New Formulations of TEV-56286

brain-icon.png
Condition(s):
Healthy Participants
Status:
Completed
Requirements:
18 years to 60 Years
Interventions:
Drug: TEV-56286 Test | Drug: TEV-56286 Reference

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

brain-icon.png
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Completed
Requirements:
18 Years to 50 Years
Interventions:
Drug: laquinimod 0.3 | Drug: laquinimod 0.6 | Other: Placebo

A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder

headache-icon.png
Condition(s):
Migraine | Major Depressive Disorder
Status:
Completed
Requirements:
18 Years to 70 Years
Interventions:
Drug: Fremanezumab | Drug: Placebo

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

cancer-icon.png
Condition(s):
Crohn Disease|Colitis, Ulcerative
Status:
Active, not recruiting
Requirements:
18 Years to 75 Years
Interventions:
Drug: TEV-48574

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

female-symbol-icon.png
Condition(s):
Contraception
Status:
Completed
Requirements:
18 Years to 45 Years
Interventions:
Drug: TV-46046|Drug: Depo-subQ Provera

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/​Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

respiratory-icon.png
Condition(s):
Asthma
Status:
Active, not recruiting
Requirements:
4 years and older
Interventions:
Drug: TEV-56248 | Drug: Albuterol sulfate

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

headache-icon.png
Condition(s):
Migraine
Status:
Completed
Requirements:
6 Years to 17 Years
Interventions:
Drug: Fremanezumab | Drug: Placebo

A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

headache-icon.png
Condition(s):
Migraine
Status:
Completed
Requirements:
6 Years to 17 Years
Interventions:
Drug: Fremanezumab | Drug: Placebo

A Study to Test if TEV-48574 is Effective in Relieving Asthma

respiratory-icon.png
Condition(s):
Asthma
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: TEV-48574 | Drug: Placebo

A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy

brain-icon.png
Condition(s):
Cerebral Palsy, Dyskinetic
Status:
Terminated
Requirements:
6 Years to 18 Years
Interventions:
Drug: TEV-50717

A Study to Test if TEV-53275 is Effective in Relieving Asthma

respiratory-icon.png
Condition(s):
Asthma
Status:
Terminated
Requirements:
18 Years and Older
Interventions:
Drug: TEV-53275 Dose A | Drug: TEV-53275 Dose B | Drug: Placebo

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia (SHINE)

psychiatry-icon.png
Condition(s):
Schizophrenia
Status:
Completed
Requirements:
13 Years to 65 Years
Interventions:
Drug: TV-46000 | Drug: Placebo

A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease (RELIEVE UCCD)

inflammation-icon.png
Condition(s):
Crohn Disease|Colitis, Ulcerative
Status:
Completed
Requirements:
18 Years to 75 Years
Interventions:
Drug: TEV-48574 | Drug: Placebo

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

pain-icon.png
Condition(s):
Fibromyalgia
Status:
Terminated
Requirements:
18 Years to 75 Years
Interventions:
Drug: Fremanezumab|Drug: Placebo

A Trial to Assess TEV-56286 at Different Doses in Healthy Participants

brain-icon.png
Condition(s):
Healthy Volunteers
Status:
Recruiting
Requirements:
18 years to 60 years
Interventions:
TEV-56286